New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
Genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new Weill Cornell Medicine research.
Years before COVID-19 turned into a global pandemic, biomolecular engineer Susan Daniel was already looking for ways to defeat it. Now she’s expanding her coronavirus studies, blending engineering with virology and data science.
Well-designed healthcare facilities lead to better patient outcomes that, in turn, result in money saved for facility owners and patients, according to new Cornell research.
Chats in the Stacks book talks this semester at Olin and Mann libraries feature faculty authors discussing politics and economics as the 2016 presidential election approaches, and other topics from poetry to religion.
Researchers from the College of Engineering and Weill Cornell Medicine will fight the spread of breast cancer and other cancers with a $9.3M, five-year grant from the National Cancer Institute.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
Six new technologies received 2013 Center for Advanced Technology awards for feasibility and proof-of-concept research to enhance the commercial value of such innovations.
Cornell University will partner with the Democratic Republic of the Congo’s Eben-Ezer University of Minembwe to offer two virtual courses, one on peace building and another on African disease patterns.